San Francisco, CA, United States of America

Alessa Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 6

Trademarks = 3

Forward Citations = 0

Loading Chart...

11 inventors (with patents filed for the assignee):

Maithili Rairkar (6 out of 6 patents)

Pujan Desai (6 out of 6 patents)

Carlos Schuler (6 out of 8 patents)

4. Pamela Munster (6 out of 9 patents)

5. John Maroney (6 out of 6 patents)

6. Scott Thomas (6 out of 10 patents)

7. Keith Hall (6 out of 42 patents)

8. Maxime Daud (4 out of 4 patents)

9. Maxime D Rappaport (4 out of 4 patents)

10. Margaret McLaughlin (4 out of 4 patents)

11. Tobias H Casab (4 out of 4 patents)

6 patents: Sort by Forward Citations

1. 12702640 - Drug implants containing enzalutamide and methods of use thereof (2026-08-11),

2. 12576063 - Implantable drug delivery devices for localized drug delivery (2026-03-17),

3. 11666528 - Drug implants containing enzalutamide and methods of use thereof (2023-06-06),

4. 11344526 - Implantable drug delivery devices for localized drug delivery (2022-05-31),

5. 11338119 - Implantable drug delivery devices for localized drug delivery (2022-05-24),

6. 11173291 - Implantable drug delivery devices for localized drug delivery (2021-11-16),

Company Overview

Alessa Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for various diseases. The company's proprietary drug delivery technology allows for targeted and sustained release of therapeutics, improving patient outcomes and quality of life. With a strong pipeline of products in development, Alessa Therapeutics aims to revolutionize the treatment of chronic conditions and improve healthcare worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#667 in San Francisco, CA

#10,583 in California

#45,030 in US

San Francisco, CA, United States of America